- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Methylergometrine is a drug used to treat a variety of conditions related to the central nervous system. It is a synthetic ergot alkaloid, derived from the ergot fungus, and is used to treat migraine headaches, postpartum hemorrhage, and other conditions. It is also used to treat hypertension, and can be used to induce labor in pregnant women. Methylergometrine works by stimulating the smooth muscle of the uterus, and can also act on the cardiovascular system to reduce blood pressure.
Methylergometrine is available in both oral and injectable forms, and is typically prescribed by a doctor. It is generally considered to be a safe and effective treatment for the conditions it is used to treat. However, it can cause side effects such as nausea, vomiting, and dizziness.
The market for Methylergometrine is largely driven by the need for treatments for conditions related to the central nervous system. Companies in the market include Pfizer, Novartis, and Merck. Show Less Read more